Herbas VPB

Print
EN | LT
LT - Peptidai ir peptidų derinys, skirti naudoti imunoterapijai gydant prostatos vėžį ir kitų rūšių vėžį
EN - PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 14/725 (2006.01)
C07K 14/47 (2006.01)
A61K 39/00 (2006.01)
A61K 38/00 (2006.01)
A61P 35/00 (2006.01)
C12N 15/115 (2006.01)
G01N 33/574 (2006.01)
European patent
(11) Number of the document 3331900
(13) Kind of document T
(96) European patent application number 16750766.4
Date of filing the European patent application 2016-08-05
(97) Date of publication of the European application 2018-06-13
(45) Date of publication and mention of the grant of the patent 2021-02-17
(46) Date of publication of the claims translation 2021-03-25
PCT application
(86) Number PCT/EP2016/068727
Date 2016-08-05
PCT application publication
(87) Number WO 2017/021527
Date 2017-02-09
Priority applications
(30) Number Date Country code
201562201289 P 2015-08-05 US
201513921 2015-08-06 GB
Inventors
(72)
MAHR, Andrea, DE
WEINSCHENK, Toni, DE
SCHOOR, Oliver, DE
FRITSCHE, Jens, DE
SINGH, Harpreet, DE
MÜLLER, Phillip, DE
LEIBOLD, Julia, AT
GOLDFINGER, Valentina, DE
Grantee
(73) Immatics Biotechnologies GmbH, Paul-Ehrlich-Strasse 15, 72076 Tübingen, DE
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Peptidai ir peptidų derinys, skirti naudoti imunoterapijai gydant prostatos vėžį ir kitų rūšių vėžį
  PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
Last renewal fee
Payment date Validity (years) Amount
2023-07-24 8 185.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-08-05